Friday's sell off was a tumultuous end to what was a great month for the biotech sector. Here's where the sector stands two months into the year:
IBB data by YCharts
Recall, the IBB was +8% at the end of January.
About Friday's selloff. This is what it looks like mapped against the entire week's trading. We've seen dips like this before in the biotech bull market and they were all bought aggressively. Monday's trading will be interesting to watch.
Here's how the big-cap biotechs are performing year to date:
The best-performing biotech and drug stocks after two months of 2014:
1. Intercept Pharma (ICPT) + 501%
2. Tekmira Pharma (TKMR) +166%
3. Rexahn Pharma (RNN)+165%
4. Imprimis Pharma (IMMY) +157%
5. Retrophin Pharma (RTRX) +152%